False Negative ECG Device Results May Increase the Risk of Adverse Events in Clinical Oncology Trials

Comparison of PR, QRS, and QT interval measurements by seven ECG interpretation programs

(2020) J. De Bie et al.   JOURNAL OF ELECTROCARDIOLOGY

QT Assessment in Early Drug Development: The Long and the Short of It

(2019) Robert M. Lester et al.   INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES

Management of QT prolongation induced by anti-cancer drugs: Target therapy and old agents. Different algorithms for different drugs

(2018) Carmela Coppola et al.   CANCER TREATMENT REVIEWS

Scientific white paper on concentration-QTc modeling

(2017) Christine Garnett et al.   JOURNAL OF PHARMACOKINETICS AND PHARMACODYNAMICS

Update on Cardiovascular Safety of Tyrosine Kinase Inhibitors: With a Special Focus on QT Interval, Left Ventricular Dysfunction and Overall Risk/Benefit

(2015) Rashmi R. Shah et al.   DRUG SAFETY

Benefits of Centralized ECG Reading in Clinical Oncology Studies

(2015) Robert Kleiman et al.   Therapeutic Innovation & Regulatory Science

The evaluation and management of drug effects on cardiac conduction (PR and QRS Intervals) in clinical development

(2013) Adel Nada et al.   AMERICAN HEART JOURNAL

Comparison of automated measurements of electrocardiographic intervals and durations by computer-based algorithms of digital electrocardiographs

(2013) Paul Kligfield et al.   AMERICAN HEART JOURNAL

Computerized Interpretation of ECGs

(2013) N.A. Mark Estes   Circulation-Arrhythmia and Electrophysiology

QT interval prolongation and the risk of torsades de pointes: essentials for clinicians

(2013) Katy E. Trinkley et al.   CURRENT MEDICAL RESEARCH AND OPINION

Detecting drug-induced prolongation of the QRS complex: New insights for cardiac safety assessment

(2012) C. Cros et al.   TOXICOLOGY AND APPLIED PHARMACOLOGY

Prevention of Torsade de Pointes in Hospital Settings

(2010) Barbara J. Drew et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Clinical characteristics of patients with drug-induced QT interval prolongation and torsade de pointes: identification of risk factors

(2008) Konstantinos P. Letsas et al.   Clinical Research in Cardiology

Challenges of characterizing proarrhythmic risk due to QTc prolongation induced by nonadjuvant anticancer agents

(2008) Nenad Sarapa et al.   Expert Opinion On Drug Safety